Daubenspeck to Head PEPID, LLC.

Business Editors and Medical/Health Writers

PEPID, LLC, the premier developer of handheld decision support tools for the medical community, announced today that Ken Daubenspeck would be assuming the position of Chief Executive Officer.

As CEO, Ken will provide PEPID, LLC with strategic leadership and vision for the organization. "I am excited at the challenges we will face in the healthcare marketplace. The trend in healthcare today is toward technology--but much of that technology provides value to the institution rather than to the medical professional and, ultimately, the patient. PEPID emphasizes serving those who directly care and serve the patient first. We believe that this is the most direct way to improve care, reduce errors, and save time--which can be allocated to serving more patients, or simply caring for that patient."

PEPID products are complete medical and drug references, combined with interactive equations and calculators to help all medical professionals provide fast, effective patient care. There are currently six versions of PEPID--ED (for emergency physicians), MD (for all physicians), RN (for clinical nurses), EMS (for emergency services professionals), MSC (for medical students) and PDC (a portable drug companion). A team of more than 80 health professionals developed PEPID--the only reference tool on the market originally developed for the PDA. All versions operate on all PDAs and PCs.

"Medicine has become increasingly complex and sophisticated in the last 2 decades," added Mr. Daubenspeck. "There are close to 1,000 new drugs available and millions of medical articles have been published in the last 20 years. Health professionals need the latest technology just to keep up. PEPID combines innovative technology with continual updates and world leading editorial contributors. These products will save lives and improve the practice of medicine. I just could not pass up the opportunity to join a winning team and help PEPID become the world leader in medical software."

Prior to joining PEPID, Mr. Daubenspeck, acted as Founder, President and CEO of Daubenspeck & Associates, a Chicago-based executive search firm. Additionally, Ken holds positions as Director of Foster Partners, ranked the 15th largest executive search firm worldwide, as well as a member of the Board of Directors for Advanced Equities, a Chicago-based investment bank in the high technology and healthcare fields.

Mark Rosenbloom, MD, will remain at PEPID as Founder and Chairman. "I was impressed by Ken's quick grasp of our business when I hired his search firm to fill a critical management position in our IT department," said Dr. Rosenbloom, "and he simply `fell in love' with our product and it's potential to improve the delivery of healthcare. I knew Ken's experience and success with his own business could serve PEPID well. I am delighted to bring someone so immensely qualified in to lead the business."

"PEPID is poised to be a breakthrough product for healthcare professionals," said Mr. Daubenspeck. "It's like having 80 other healthcare professionals standing behind you, providing you a `hallway consult'--without ever having to leave the patient. Patients may now wonder why their physician or nurse is using a PDA at their bedside, but soon they will wonder why their physician did not bring it, just as they would wonder if the physician forgot their stethoscope."

And, this isn't just a phenomenon in the US. "We've had requests from relief workers in Afghanistan who are treating women & children on a daily basis. In the field, seldom do physicians have the tools often taken for granted in most medical facilities," remarked Mr. Daubenspeck. "They love the fact that EVERY medical condition is covered, including extensive sections on environmental emergencies and tropical diseases. In addition, the comprehensive drug sections and automated dosage calculators allow them to accurately dose patients based on their weight. And finally the international scope with metric converters, foreign drug trade names, international lab units, makes it indispensable for the foreign relief worker."

About PEPID

PEPID, the premier medical and drug reference tool for the PDA, is designed to assist in the reduction of medical errors and improve patient outcomes. It provides healthcare professionals access to the most comprehensive, accurate and current pharmacological and clinical information at the point-of-care via personal digital assistants (PDA's). PEPID was founded in 1994 by Dr. Mark Rosenbloom, a Board-Certified Emergency Physician at Northwestern University School of Medicine. PEPID covers medical and trauma topics typically encountered in emergency and primary care settings.

PEPID is the market leader in providing medical databases for personal digital assistants (PDA's), delivers six database tools for healthcare practitioners including emergency physicians, MD's, registered nurses, medical students, EMS professionals and pharmacology professionals.

For more information about PEPID products, visit www.pepid.com